MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
*Driving Forces: Market Research, Intelligence, Analysis, Datapoints, Databases & Trends
*Driving Forces: Life Sciences, Medical Devices & Health Information Technology
2025: Top 10 U.S. Biopharma Clusters 2025
Massachusetts
*Industry: Massachusetts
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT)*
Organization & Developments: Checkpoint Therapeutics
Parents
Checkpoint Therapeutics, Inc. (NASDAQ:CKPT)*
Children
2019: Breakout In Focus: Checkpoint Therapeutics_seekingalpha.com
2020: Biotech Analysis Central Preview Series: Checkpoint Therapeutics
2021: Checking In On Checkpoint Therapeutics
2022: Checkpoint: Strong Data, But Comes With Risks_ seekingalpha.com
2024: Checkpoint Therapeutics Announces Cosibelimab Longer-Term Results in Advanced Cutaneous Squamous Cell Carcinoma Presented at ESMO Congress 2024
2024: Checkpoint Therapeutics Sets FDA Review Date, Secures $9.2M Funding Boost Amid Q3 Loss
2024: Checkpoint Therapeutics takes on Merck's mighty Keytruda with FDA approval for Unloxcyt in skin cancer
2024: Checkpoint Therapeutics: A Binary Bet On FDA Approval And Cosibelimab's Market Success_
2024: Checkpoint Therapeutics: Preparing For Cosibelimab's Upcoming PDUFA Date_seekingalpha.com
2024: Checkpoint Therapeutics: Updating My Strategy After Unloxcyt's Approval
2024: FDA Approves Checkpoint Therapeutics' Skin Cancer Drug One Year After Rejection
2025: Checkpoint Therapeutics: Pivoting From Approval To Gutsy Next Shot On Goal_seekingalpha.com
Jumps
Finance & Acquisitions: Checkpoint Therapeutics
Key People: Checkpoint Therapeutics